Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3928/01477447-20110922-05 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Merger mania: mergers and acquisitions in the generic drug sector from 1995 to 2016.
Global Health
August 2017
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 1020 Pine Avenue West, Montreal, QC, H3A 1A2, Canada.
Background: Drug shortages and increasing generic drug prices are associated with low levels of competition. Mergers and acquisitions impact the level of competition. Record merger and acquisition activity was reported for the pharmaceutical sector in 2014/15, yet information on mergers and acquisitions in the generic drug sector are absent from the literature.
View Article and Find Full Text PDFAddressing Pricing Power in Integrated Delivery: The Limits of Antitrust.
J Health Polit Policy Law
August 2015
Prices are the major driver of why the United States spends so much more on health care than other countries do. The pricing power that hospitals have garnered recently has resulted from consolidated delivery systems and concentrated markets, leading to enhanced negotiating leverage. But consolidation may be the wrong frame for viewing the problem of high and highly variable prices; many "must-have" hospitals achieve their pricing power from sources other than consolidation, for example, reputation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!